Highlights from ASH 2024, Leukemia Edition (Continued)
Click Here to Manage Email Alerts
In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition with a focus on leukemia, as well as Healio’s top headlines from the meeting.
Aaron T. Gerds, MD, MS, discusses how socioeconomic disparities affect access to allogeneic hematopoietic stem cell transplantation for people with acute myeloid leukemia. :24
Hua Zhang, MD, PhD, reviews findings of bicistronic chimeric antigen receptor T-cell therapy induced durable response for most children with relapsed or refractory B-lineage acute lymphoblastic leukemia. 6:29
Moath Albliwi, MD, discusses the results of a study he co-presented examining treatment of elderly patients with acute myeloid leukemia. 00:00
Alexey Danilov, MD, PhD, reviews the efficacy of epcoritamab among heavily pretreated patients with advanced chronic lymphocytic leukemia. 00:00
Lee Greenberger, PhD, discusses results of the AMPLIFY study. 16:30
Read the full coverage here:
Socioeconomic factors a barrier to HSCT for people with acute myeloid leukemia
Bicistronic CAR-T effective for children with relapsed B-ALL
VIDEO: Study probes treatment of elderly patients with acute myeloid leukemia
First-line regimen improves PFS in chronic lymphocytic leukemia
Epcoritamab exhibits ‘very encouraging’ efficacy in heavily pretreated CLL
Addition of blinatumomab to chemotherapy improves outcomes for children with B-cell ALL
Collapse
Click Here to Manage Email Alerts
